{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:52:17Z","timestamp":1781635937297,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction. The diagnosis typically relies on clinical features, serologic testing, and neurophysiological assessment but provocation tests such as the edrophonium test can provide rapid supportive information; however, data on its diagnostic performance are limited. Thus, we aimed to evaluate the diagnostic performance and safety of the edrophonium test in MG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective case\u2013control study of patients who underwent an edrophonium test at the Department of Neurology of the Medical University of Vienna between January 1991 and January 2024. We calculated sensitivity, specificity, and likelihood ratios and performed a multivariable logistic regression analysis to identify variables associated with a positive edrophonium test. Additionally, we assessed the safety of the edrophonium test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 182 patients with MG (41.2% female; mean age 55.8 years) and 324 controls (55.2% female; mean age 53.6 years). The edrophonium test had a sensitivity of 83.5% and a specificity of 87.7% in diagnosing MG. Patients with a decrement after repetitive nerve stimulation had higher odds of a positive response to the edrophonium test (OR 3.79, 95% CI 1.48\u201310.33,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0067), while odds were lower in patients with MuSK-MG compared to patients with AChR-MG (OR 0.08, 95% CI 0.01\u20130.82,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0254). Adverse events were reported in 58 patients (11.5%), in most of whom (53 patients, 91.4%) they were mild.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We provide data on the diagnostic performance and safety of the edrophonium test, supporting its use as an adjunctive diagnostic test for the diagnosis of MG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-026-00468-6","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:29:41Z","timestamp":1770650981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic performance and safety of the edrophonium test in myasthenia gravis: a retrospective case-control study"],"prefix":"10.1186","volume":"8","author":[{"given":"Omar","family":"Keritam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Bettina","family":"Kr\u00e4utler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Gharib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnayer Ahmed","family":"Jabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Rinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Zulehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-4572","authenticated-orcid":false,"given":"Jakob","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"1","key":"468_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus, N. E., Tzartos, S., Evoli, A., Palace, J., Burns, T. M., & Verschuuren, J. (2019). Myasthenia Gravis. Nat Rev Dis Primers, 5(1), 30. https:\/\/doi.org\/10.1038\/s41572-019-0079-y","journal-title":"Nat Rev Dis Primers"},{"key":"468_CR2","doi-asserted-by":"publisher","first-page":"175628642312132","DOI":"10.1177\/17562864231213240","volume":"16","author":"H Wiendl","year":"2023","unstructured":"Wiendl, H., Abicht, A., Chan, A., Della Marina, A., Hagenacker, T., Hekmat, K., et al. (2023). Guideline for the management of myasthenic syndromes. Therapeutic Advances in Neurological Disorders, 16, 17562864231213240. https:\/\/doi.org\/10.1177\/17562864231213240","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"1","key":"468_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s42466-025-00453-5","volume":"7","author":"H Pressler","year":"2025","unstructured":"Pressler, H., Haddy, I., Daugherty, C., Postila, V., & Meisel, A. (2025). Paraneoplastic Lambert-Eaton myasthenic syndrome associated with non-small cell lung cancer: Data from the European LEMS registry and systematic review. Neurol Res Pract, 7(1), 95. https:\/\/doi.org\/10.1186\/s42466-025-00453-5","journal-title":"Neurol Res Pract"},{"issue":"10","key":"468_CR4","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1093\/brain\/awad153","volume":"146","author":"NM Allen","year":"2023","unstructured":"Allen, N. M., O\u2019Rahelly, M., Eymard, B., Chouchane, M., Hahn, A., Kearns, G., et al. (2023). The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD). Brain, 146(10), 4233\u20134246. https:\/\/doi.org\/10.1093\/brain\/awad153","journal-title":"Brain"},{"issue":"1","key":"468_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s42466-023-00280-6","volume":"5","author":"M Wassenberg","year":"2023","unstructured":"Wassenberg, M., Hahn, A., Muck, A., & Kramer, H. H. (2023). Maternal Immunoglobulin treatment can reduce severity of fetal acetylcholine receptor antibody-associated disorders (FARAD). Neurol Res Pract, 5(1), 58. https:\/\/doi.org\/10.1186\/s42466-023-00280-6","journal-title":"Neurol Res Pract"},{"key":"468_CR6","doi-asserted-by":"publisher","unstructured":"Keritam, O., Vincent, A., Zimprich, F., & Cetin, H. (2024). A clinical perspective on muscle specific kinase antibody positive myasthenia Gravis. Frontiers in Immunology, 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1502480","DOI":"10.3389\/fimmu.2024.1502480"},{"issue":"10","key":"468_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus, N. E., & Verschuuren, J. J. (2015). Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurology, 14(10), 1023\u20131036. https:\/\/doi.org\/10.1016\/S1474-4422(15)00145-3","journal-title":"Lancet Neurology"},{"key":"468_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00916-w","author":"R Iorio","year":"2024","unstructured":"Iorio, R. (2024). Myasthenia gravis: The changing treatment landscape in The era of molecular Therapies. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/s41582-023-00916-w","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"468_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s42466-023-00252-w","volume":"5","author":"H Menghesha","year":"2023","unstructured":"Menghesha, H., Schroeter, M., Nelke, C., Ruck, T., Schlachtenberger, G., Welskop, C., et al. (2023). The impact of thymectomy in subgroups of myasthenia Gravis patients: A single center longitudinal observation. Neurol Res Pract, 5(1), 24. https:\/\/doi.org\/10.1186\/s42466-023-00252-w","journal-title":"Neurol Res Pract"},{"issue":"8","key":"468_CR10","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer, N., Ruck, T., Fuhr, P., Gold, R., Hohlfeld, R., Marx, A., et al. (2016). Clinical features, pathogenesis, and treatment of myasthenia gravis: A supplement to the guidelines of the German neurological society. Journal of Neurology, 263(8), 1473\u20131494. https:\/\/doi.org\/10.1007\/s00415-016-8045-z","journal-title":"Journal of Neurology"},{"issue":"4","key":"468_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","volume":"263","author":"S Binks","year":"2016","unstructured":"Binks, S., Vincent, A., & Palace, J. (2016). Myasthenia gravis: A clinical-immunological update. Journal of Neurology, 263(4), 826\u2013834. https:\/\/doi.org\/10.1007\/s00415-015-7963-5","journal-title":"Journal of Neurology"},{"issue":"5","key":"468_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli, M. N., & Sanders, D. B. (2009). Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity. Lancet Neurology, 8(5), 475\u2013490. https:\/\/doi.org\/10.1016\/S1474-4422(09)70063-8","journal-title":"Lancet Neurology"},{"issue":"4","key":"468_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mus.20498","volume":"33","author":"SJ Oh","year":"2006","unstructured":"Oh, S. J., Hatanaka, Y., Hemmi, S., Young, A. M., Scheufele, M. L., Nations, S. P., et al. (2006). Repetitive nerve stimulation of facial muscles in musk antibody-positive myasthenia Gravis. Muscle and Nerve, 33(4), 500\u2013504. https:\/\/doi.org\/10.1002\/mus.20498","journal-title":"Muscle and Nerve"},{"issue":"7","key":"468_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","volume":"16","author":"M Benatar","year":"2006","unstructured":"Benatar, M. (2006). A systematic review of diagnostic studies in myasthenia Gravis. Neuromuscular Disorders, 16(7), 459\u2013467. https:\/\/doi.org\/10.1016\/j.nmd.2006.05.006","journal-title":"Neuromuscular Disorders"},{"issue":"12","key":"468_CR15","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.clinph.2004.05.024","volume":"115","author":"J Costa","year":"2004","unstructured":"Costa, J., Evangelista, T., Conceicao, I., & de Carvalho, M. (2004). Repetitive nerve stimulation in myasthenia gravis\u2013relative sensitivity of different muscles. Clinical Neurophysiology, 115(12), 2776\u20132782. https:\/\/doi.org\/10.1016\/j.clinph.2004.05.024","journal-title":"Clinical Neurophysiology"},{"issue":"1","key":"468_CR16","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1038\/s41598-023-30154-5","volume":"13","author":"M Tomschik","year":"2023","unstructured":"Tomschik, M., Renaud, E., Jager, F., Paternostro, C., Rath, J., Rinner, W., et al. (2023). The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia Gravis. Scientific Reports, 13(1), 2985. https:\/\/doi.org\/10.1038\/s41598-023-30154-5","journal-title":"Scientific Reports"},{"issue":"6","key":"468_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.clinph.2013.11.005","volume":"125","author":"L Padua","year":"2014","unstructured":"Padua, L., Caliandro, P., Di Iasi, G., Pazzaglia, C., Ciaraffa, F., & Evoli, A. (2014). Reliability of SFEMG in diagnosing myasthenia gravis: Sensitivity and specificity calculated on 100 prospective cases. Clinical Neurophysiology, 125(6), 1270\u20131273. https:\/\/doi.org\/10.1016\/j.clinph.2013.11.005","journal-title":"Clinical Neurophysiology"},{"key":"468_CR18","first-page":"45","volume":"19","author":"GA Nicholson","year":"1983","unstructured":"Nicholson, G. A., McLeod, J. G., & Griffiths, L. R. (1983). Comparison of diagnostic tests in myasthenia Gravis. Clin Exp Neurol, 19, 45\u201349.","journal-title":"Clin Exp Neurol"},{"key":"468_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000002346","author":"A Handzic","year":"2025","unstructured":"Handzic, A., Furter, M. P., Messmer, B. C., Wirth, M. A., Valko, Y., Fierz, F. C., et al. (2025). Multivariable prediction model for suspected ocular myasthenia gravis: Development and validation. Journal of Neuro-Ophthalmology. https:\/\/doi.org\/10.1097\/WNO.0000000000002346","journal-title":"Journal of Neuro-Ophthalmology"},{"issue":"10","key":"468_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s004150050160","volume":"244","author":"AP Batocchi","year":"1997","unstructured":"Batocchi, A. P., Evoli, A., Majolini, L., LoMonaco, M., Padua, L., Ricci, E., et al. (1997). Ocular palsies in the absence of other neurological or ocular symptoms: Analysis of 105 cases. Journal of Neurology, 244(10), 639\u2013645. https:\/\/doi.org\/10.1007\/s004150050160","journal-title":"Journal of Neurology"},{"issue":"7","key":"468_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S1388-2457(00)00307-2","volume":"111","author":"L Padua","year":"2000","unstructured":"Padua, L., Stalberg, E., LoMonaco, M., Evoli, A., Batocchi, A., & Tonali, P. (2000). SFEMG in ocular myasthenia Gravis diagnosis. Clinical Neurophysiology, 111(7), 1203\u20131207. https:\/\/doi.org\/10.1016\/S1388-2457(00)00307-2","journal-title":"Clinical Neurophysiology"},{"key":"468_CR22","doi-asserted-by":"publisher","first-page":"175628642110355","DOI":"10.1177\/17562864211035544","volume":"14","author":"T Warnecke","year":"2021","unstructured":"Warnecke, T., Im, S., Labeit, B., Zwolinskaya, O., Suntrup-Kruger, S., Oelenberg, S., et al. (2021). Detecting myasthenia Gravis as a cause of unclear dysphagia with an endoscopic tensilon test. Therapeutic Advances in Neurological Disorders, 14, 17562864211035544. https:\/\/doi.org\/10.1177\/17562864211035544","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"8","key":"468_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/archneur.1986.00520080081029","volume":"43","author":"RB Daroff","year":"1986","unstructured":"Daroff, R. B. (1986). The office tensilon test for ocular myasthenia Gravis. Archives of Neurology, 43(8), 843\u2013844. https:\/\/doi.org\/10.1001\/archneur.1986.00520080081029","journal-title":"Archives of Neurology"},{"issue":"15","key":"468_CR24","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.293.15.1906","volume":"293","author":"K Scherer","year":"2005","unstructured":"Scherer, K., Bedlack, R. S., & Simel, D. L. (2005). Does this patient have myasthenia gravis? Journal of the American Medical Association, 293(15), 1906\u20131914. https:\/\/doi.org\/10.1001\/jama.293.15.1906","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"468_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jama.1952.03680040007002","volume":"150","author":"KE Osserman","year":"1952","unstructured":"Osserman, K. E., & Kaplan, L. I. (1952). Rapid diagnostic test for myasthenia Gravis - Increased muscle Strength, without Fasciculations, after intravenous administration of edrophonium (Tensilon) chloride. Jama-J Am Med Assoc, 150(4), 265\u2013268. https:\/\/doi.org\/10.1001\/jama.1952.03680040007002","journal-title":"Jama-J Am Med Assoc"},{"issue":"8","key":"468_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/Wnl.37.8.1383","volume":"37","author":"KD Sethi","year":"1987","unstructured":"Sethi, K. D., Rivner, M. H., & Swift, T. R. (1987). Ice pack test for Myasthenia-Gravis. Neurology, 37(8), 1383\u20131385. https:\/\/doi.org\/10.1212\/Wnl.37.8.1383","journal-title":"Neurology"},{"issue":"3","key":"468_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1600-0404.1994.tb01667.x","volume":"89","author":"M Ertas","year":"1994","unstructured":"Ertas, M., Arac, N., Kumral, K., & Tuncbay, T. (1994). Ice test as a simple Diagnostic-Aid for Myasthenia-Gravis. Acta Neurologica Scandinavica, 89(3), 227\u2013229.","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7","key":"468_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00415-003-1121-1","volume":"250","author":"A Czaplinski","year":"2003","unstructured":"Czaplinski, A., Steck, A. J., & Fuhr, P. (2003). Ice pack test for myasthenia gravis - A simple, noninvasive and safe diagnostic method. Journal of Neurology, 250(7), 883\u2013884. https:\/\/doi.org\/10.1007\/s00415-003-1121-1","journal-title":"Journal of Neurology"},{"issue":"4","key":"468_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s0002-9394(14)71863-x","volume":"114","author":"GE Coll","year":"1992","unstructured":"Coll, G. E., & Demer, J. L. (1992). The edrophonium-Hess screen test in the diagnosis of ocular myasthenia Gravis. American Journal of Ophthalmology, 114(4), 489\u2013493. https:\/\/doi.org\/10.1016\/s0002-9394(14)71863-x","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"468_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/mus.25374","volume":"55","author":"H Bou Ali","year":"2017","unstructured":"Bou Ali, H., Salort-Campana, E., Grapperon, A. M., Gallard, J., Franques, J., Sevy, A., et al. (2017). New strategy for improving the diagnostic sensitivity of repetitive nerve stimulation in myasthenia Gravis. Muscle and Nerve, 55(4), 532\u2013538. https:\/\/doi.org\/10.1002\/mus.25374","journal-title":"Muscle and Nerve"},{"issue":"3","key":"468_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0168-5597(93)90130-h","volume":"89","author":"RP Kennett","year":"1993","unstructured":"Kennett, R. P., & Fawcett, P. R. (1993). Repetitive nerve stimulation of Anconeus in the assessment of neuromuscular transmission disorders. Electroencephalography and Clinical Neurophysiology, 89(3), 170\u2013176. https:\/\/doi.org\/10.1016\/0168-5597(93)90130-h","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"key":"468_CR32","doi-asserted-by":"publisher","first-page":"123047","DOI":"10.1016\/j.jns.2024.123047","volume":"461","author":"R Ricciardi","year":"2024","unstructured":"Ricciardi, R., Latini, E., Guida, M., Koneczny, I., Lucchi, M., Maestri, M., et al. (2024). Acetylcholinesterase inhibitors are ineffective in MuSK-antibody positive myasthenia gravis: Results of a study on 202 patients. Journal of the Neurological Sciences, 461, 123047. https:\/\/doi.org\/10.1016\/j.jns.2024.123047","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"468_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0008-4182(00)80007-1","volume":"35","author":"EB Ing","year":"2000","unstructured":"Ing, E. B., Ing, S. Y., Ing, T., & Ramocki, J. A. (2000). The complication rate of edrophonium testing for suspected myasthenia Gravis. Canadian Journal of Ophthalmology, 35(3), 141\u2013144. https:\/\/doi.org\/10.1016\/s0008-4182(00)80007-1. discussion 5.","journal-title":"Canadian Journal of Ophthalmology"},{"key":"468_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fnins.2016.00226","volume":"10","author":"S Matsumoto","year":"2016","unstructured":"Matsumoto, S., Murakami, N., Koizumi, H., Takahashi, M., Izumi, Y., & Kaji, R. (2016). Edrophonium challenge test for blepharospasm. Front Neurosci, 10, 226. https:\/\/doi.org\/10.3389\/fnins.2016.00226","journal-title":"Front Neurosci"},{"issue":"18","key":"468_CR35","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.2169\/internalmedicine.8555-16","volume":"56","author":"S Matsumoto","year":"2017","unstructured":"Matsumoto, S., Murakami, N., Koizumi, H., Takahashi, M., Izumi, Y., & Kaji, R. (2017). Evaluation of the edrophonium challenge test for cervical dystonia. Internal Medicine, 56(18), 2415\u20132421. https:\/\/doi.org\/10.2169\/internalmedicine.8555-16","journal-title":"Internal Medicine"},{"issue":"6","key":"468_CR36","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1007\/s00415-022-10986-3","volume":"269","author":"K Yoganathan","year":"2022","unstructured":"Yoganathan, K., Stevenson, A., Tahir, A., Sadler, R., Radunovic, A., & Malek, N. (2022). Bedside and laboratory diagnostic testing in myasthenia. Journal of Neurology, 269(6), 3372\u20133384. https:\/\/doi.org\/10.1007\/s00415-022-10986-3","journal-title":"Journal of Neurology"},{"issue":"2","key":"468_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10072-017-3194-0","volume":"39","author":"G Sciacca","year":"2018","unstructured":"Sciacca, G., Reggio, E., Mostile, G., Nicoletti, A., Drago, F., Salomone, S., et al. (2018). Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia Gravis. Neurological Sciences : official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 39(2), 341\u2013345. https:\/\/doi.org\/10.1007\/s10072-017-3194-0","journal-title":"Neurological Sciences : official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00468-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:04Z","timestamp":1781632684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00468-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00468-6","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Medical University of Vienna (EK No. 1218\/2024) in March 2024. The requirement to obtain patient consent was waived for this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}